ASX:QIN

Quintis (QIN) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
QIN stock logo

About Quintis Stock (ASX:QIN)

Quintis Limited, formerlyTFS Corporation Ltd, is engaged in the manufacture, sale, distribution, management, ownership and promotion of sandalwood plantations. The Company's segments include Plantation Management, Finance, Sandalwood Products and Pharmaceutical. The Plantation Management segment is responsible for the promotion and sales of Indian sandalwood lots to investors, called growers. The Plantation Management segment is also responsible for the establishment, maintenance and harvesting of Indian sandalwood plantations on behalf of the growers and group owned plantations. The Finance segment is responsible for providing finance to growers to purchase sandalwood lots. The Sandalwood Products segment is responsible for the manufacture of sandalwood oil and products for resale both domestic and internationally. The Pharmaceutical segment is responsible for research and development of pharmaceutical and biopharmaceutical products for commercializing.

QIN Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive QIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quintis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/14/2017
Today
4/25/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Julius Luke Matthys
    Interim Chief Executive Officer
  • Alistair Stevens
    Chief Financial Officer
  • Paul Castella
    Chief Executive Officer of Santalis Pharmaceuticals Inc
  • Quentin Heath Megson
    General Manager - Operations and Corporate Services
  • Ian Ross Thompson
    Senior Adviser
  • Simon Jonathan Storm
    Corporate Secretary
  • Dalton Leslie Gooding (Age 59)
    Independent Non-Executive Chairman of the Board
  • Giovanni Groppoli
    Non-Executive Independent Director
  • Michael Graham Doveton Kay (Age 56)
    Non-Executive Independent Director

QIN Stock Analysis - Frequently Asked Questions

How were Quintis' earnings last quarter?

Quintis Limited (ASX:QIN) posted its quarterly earnings data on Tuesday, November, 14th. The company reported ($1.07) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by $1.12.

What other stocks do shareholders of Quintis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Quintis investors own include White Cliff Minerals (WCN) and CAR Group (CAR).

This page (ASX:QIN) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners